Literature DB >> 27554664

Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma.

Darragh S Gogarty1,2, Paul Lennon3, Sandra Deady4, J Barry O'Sullivan5, Orla McArdle6, Mary Leader7, Patrick Sheahan8, James Paul O'Neill3.   

Abstract

This study aims to determine the survival impact of patient characteristics and treatment options associated with the early stage oral cavity squamous cell carcinoma, OCSCC. The methods are analysis of Irish cancer database examining T1/2, N0, and M0 cases of OCSCC from 1997 to 2007 inclusive. In total, 397 cases were identified. Anterolateral tongue accounted for 52.9 % of cases. Increased age at diagnosis and smoking are independent prognostic survival indicators associated with poorer outcomes. Surgery as the initial intervention was associated with significantly better survival outcomes, while surgery and adjuvant radiotherapy significantly worse outcomes. Surgical intervention is recommended as the first-line treatment in the early stage OCSCC in combination with elective neck dissection.

Entities:  

Keywords:  Adult; Node negative; Oral cavity; Radiotherapy; Survival

Mesh:

Year:  2016        PMID: 27554664     DOI: 10.1007/s00405-016-4267-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  39 in total

1.  Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.

Authors:  Chun-Ta Liao; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Shu-Hang Ng; Li-Yu Lee; Chuen Hsueh; I-How Chen; Shiang-Fu Huang; Chung-Jan Kang; Tzu-Chen Yen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-13       Impact factor: 7.038

2.  Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma.

Authors:  A P Yuen; K Y Lam; A C Chan; W I Wei; L K Lam; W K Ho; C M Ho
Journal:  Am J Surg       Date:  1999-01       Impact factor: 2.565

3.  Does elective neck dissection in T1/T2 carcinoma of the oral tongue and floor of the mouth influence recurrence and survival rates?

Authors:  Natalie Kelner; José Guilherme Vartanian; Clóvis Antônio Lopes Pinto; Cláudia Malheiros Coutinho-Camillo; Luiz Paulo Kowalski
Journal:  Br J Oral Maxillofac Surg       Date:  2014-05-17       Impact factor: 1.651

4.  Carcinoma of the oral cavity. factors affecting treatment failure at the primary site and neck.

Authors:  J P Shah; R A Cendon; H W Farr; E W Strong
Journal:  Am J Surg       Date:  1976-10       Impact factor: 2.565

5.  Adjuvant radiotherapy and health-related quality of life of patients at intermediate risk of recurrence following primary surgery for oral squamous cell carcinoma.

Authors:  F Bekiroglu; N Ghazali; R Laycock; C Katre; D Lowe; S N Rogers
Journal:  Oral Oncol       Date:  2011-08-09       Impact factor: 5.337

6.  A population-based study of therapy and survival for patients with head and neck cancer treated in the community.

Authors:  Claudio Dansky Ullmann; Linda C Harlan; Vickie L Shavers; Jennifer L Stevens
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

7.  Survival and patterns of relapse in patients with oral tongue cancer.

Authors:  Kyle E Rusthoven; David Raben; John I Song; Madeleine Kane; Taghrid A Altoos; Changhu Chen
Journal:  J Oral Maxillofac Surg       Date:  2009-11-25       Impact factor: 1.895

8.  Chronological shifts and changing causes of death after radiotherapy for early-stage oral cancer.

Authors:  Rina Fujisawa; Hitoshi Shibuya; Naoki Harata; Keiko Yuasa-Nakagawa; Kazuma Toda; Keiji Hayashi
Journal:  Int J Clin Oncol       Date:  2013-02-02       Impact factor: 3.402

9.  Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.

Authors:  Kyle Rusthoven; Ari Ballonoff; David Raben; Changhu Chen
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

10.  The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals.

Authors:  Mark A Bellis; Karen Hughes; James Nicholls; Nick Sheron; Ian Gilmore; Lisa Jones
Journal:  BMC Public Health       Date:  2016-02-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.